iPlan Flow software enables targeted medication delivery for the treatment of brain tumors. The National Ministry for Education and Research in Germany and the National Institutes of Health in the U.S have provided research supporting the software’s ability to allow surgeons to assess where and how medications need to be infused in order to reach specific cells within the brain.
iPlan Flow facilitates targeted drug delivery to specific areas of the brain and can make the process considerably safer and more effective. Based on ongoing research from Dr. Raghu Raghavan and Dr. Martin Brady, both of Baltimore, MD, a computer uses magnetic resonance imaging to render an individual 3-D map of the patient’s brain. This map then calculates the distribution patterns of the medication. With this information, the doctor can now preoperatively identify the location where the medication needs to be delivered.

Related Content

News | Radiation Oncology

October 21, 2021 — Novocure announced 15 presentations on Tumor Treating Fields (TTFields) will be featured at the ...

Time October 21, 2021
arrow
News | Radiation Oncology

August 30, 2021 — RaySearch Laboratories AB (publ) will be showcasing the latest oncology software innovations at ESTRO ...

Time August 30, 2021
arrow
News | Treatment Planning

August 3, 2021 — LAP announced it has strengthened its partnership with leading integrated oncology care provider ...

Time August 03, 2021
arrow
News | RSNA

July 21, 2021 — Registration is now open for the Radiological Society of North America (RSNA) 107th Scientific Assembly ...

Time July 21, 2021
arrow
Feature | Treatment Planning | Information provided by Grand View Research

The rapid increase in global cancer prevalence is driving the demand for innovative and accurate oncology treatment ...

Time July 07, 2021
arrow
News | Oncology Information Management Systems (OIMS)

June 28, 2021 — RaySearch Laboratories AB announced an extension of its relationship with Centre hospitalier ...

Time June 28, 2021
arrow
News | Artificial Intelligence

April 7, 2021 — Vysioneer, a leader in artificial intelligence (AI) for cancer care, announced it received the U.S. Food ...

Time April 07, 2021
arrow
News | Treatment Planning

March 10, 2021 — Brainlab announced the acquisition of Mint Medical GmbH, a Heidelberg-based company that develops image ...

Time March 10, 2021
arrow
Feature | Treatment Planning | By Melinda Taschetta-Millane

The decision to offer radiation after prostatectomy for patients with recurrent prostate cancer is quite complex, and ...

Time March 05, 2021
arrow
Subscribe Now